scholarly journals Effect of Nanoclay Addition on the Properties of Polycaprolactone Nanocomposite Scaffolds Containing Adipose Derived Mesenchymal Stem Cells used in Soft Tissue Engineering

2021 ◽  
Vol 39 (4) ◽  
2015 ◽  
Vol 16 (4) ◽  
pp. 045001 ◽  
Author(s):  
Jian-Feng Pan ◽  
Shuo Li ◽  
Chang-An Guo ◽  
Du-Liang Xu ◽  
Feng Zhang ◽  
...  

1997 ◽  
Vol 3 (4) ◽  
pp. 321-328 ◽  
Author(s):  
Una Chen ◽  
Ruth Esser ◽  
Katja Kotlenga ◽  
Sabine Neis ◽  
Darisuren Anhlan ◽  
...  

Biomaterials ◽  
2014 ◽  
Vol 35 (6) ◽  
pp. 1914-1923 ◽  
Author(s):  
Hoi Ki Cheung ◽  
Tim Tian Y. Han ◽  
Dale M. Marecak ◽  
John F. Watkins ◽  
Brian G. Amsden ◽  
...  

2021 ◽  
Vol 22 (2) ◽  
pp. 684
Author(s):  
Parisa Khayambashi ◽  
Janaki Iyer ◽  
Sangeeth Pillai ◽  
Akshaya Upadhyay ◽  
Yuli Zhang ◽  
...  

Tissue engineering has been an inveterate area in the field of regenerative medicine for several decades. However, there remains limitations to engineer and regenerate tissues. Targeted therapies using cell-encapsulated hydrogels, such as mesenchymal stem cells (MSCs), are capable of reducing inflammation and increasing the regenerative potential in several tissues. In addition, the use of MSC-derived nano-scale secretions (i.e., exosomes) has been promising. Exosomes originate from the multivesicular division of cells and have high therapeutic potential, yet neither self-replicate nor cause auto-immune reactions to the host. To maintain their biological activity and allow a controlled release, these paracrine factors can be encapsulated in biomaterials. Among the different types of biomaterials in which exosome infusion is exploited, hydrogels have proven to be the most user-friendly, economical, and accessible material. In this paper, we highlight the importance of MSCs and MSC-derived exosomes in tissue engineering and the different biomaterial strategies used in fabricating exosome-based biomaterials, to facilitate hard and soft tissue engineering.


2020 ◽  
Vol 15 (7) ◽  
pp. 602-606
Author(s):  
Kun Ji ◽  
Ling Ding ◽  
Xi Chen ◽  
Yun Dai ◽  
Fangfang Sun ◽  
...  

Mesenchymal Stem Cells (MSCs) exhibit enormous therapeutic potential because of their indispensable regenerative, reparative, angiogenic, anti-apoptotic, and immunosuppressive properties. MSCs can best differentiate into mesodermal cell lineages, including osteoblasts, adipocytes, muscle cells, endothelial cells and chondrocytes. Specific differentiation of MSCs could be induced through limited conditions. In addition to the relevant differentiation factors, drastic changes also occur in the microenvironment to conduct it in an optimal manner for particular differentiation. Recent evidence suggests that the mitochondria participate in the regulating of direction and process of MSCs differentiation. Therefore, our current review focuses on how mitochondria participate in both osteogenesis and adipogenesis of MSC differentiation. Besides that, in our current review, we try to provide a further understanding of the relationship between the behavior of mitochondria and the direction of MSC differentiation, which could optimize current cellular culturing protocols for further facilitating tissue engineering by adjusting specific conditions of stem cells.


Sign in / Sign up

Export Citation Format

Share Document